Literature DB >> 12244203

Mucosal plasma cell repertoire during HIV-1 infection.

Ronald W Scamurra1, Douglas B Nelson, Xue Mei Lin, Darren J Miller, Gregg J Silverman, Tim Kappel, Joseph R Thurn, Erin Lorenz, Anjali Kulkarni-Narla, Edward N Janoff.   

Abstract

Impaired development of local Ab responses may predispose HIV-1-infected patients to an increased rate, severity, and duration of mucosal infections. We characterized the repertoire of Ig-producing cells in the intestinal effector compartment (the lamina propria) of HIV-1-infected (n = 29) and seronegative control (n = 27) subjects. The density of Ig-producing cells per area was similar in both groups. However, the proportions of IgA-producing cells were lower in both the duodenum and colon from HIV-1-infected patients compared with those of control subjects (p < 0.05), with compensatory increases in IgG-producing cells in the colon and IgM-producing cells in the duodenum. Similarly, among Abs in the lumen the proportions of IgA were also decreased and the proportions of IgG were increased among HIV-1-infected patients. On a molecular level, V(H) gene repertoire analyses by RT-PCR revealed comparable proportions of the V(H)3 family among duodenal IgA transcripts (50-53%) from both groups. V(H)3 expression was decreased only for IgM among patients with advanced HIV-1 disease (n = 6) compared with that of control subjects (n = 8) (48 +/- 8 vs 62 +/- 13%; p < 0.01). Moreover, the frequencies of individual IgM and IgA V(H)3 genes were comparable in each group, including rates of putative HIV-1 gp120-binding V(H)3 genes (V3-23, V3-30, V3-30/3-30.5). We conclude that, despite a decrement in local IgA producing cells, the density and molecular V(H) repertoire of mucosal plasma cells are relatively intact among patients with HIV-1 infection. These data suggest that HIV-1-infected patients use functional regulatory mechanisms to provide sufficient V(H) diversity and effective induction and differentiation of mucosal B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244203     DOI: 10.4049/jimmunol.169.7.4008

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Profiling human antibody responses by integrated single-cell analysis.

Authors:  Adebola O Ogunniyi; Brittany A Thomas; Timothy J Politano; Navin Varadarajan; Elise Landais; Pascal Poignard; Bruce D Walker; Douglas S Kwon; J Christopher Love
Journal:  Vaccine       Date:  2014-03-03       Impact factor: 3.641

2.  Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut.

Authors:  Natalia Shulzhenko; Andrey Morgun; William Hsiao; Michele Battle; Michael Yao; Oksana Gavrilova; Marlene Orandle; Lloyd Mayer; Andrew J Macpherson; Kathy D McCoy; Claire Fraser-Liggett; Polly Matzinger
Journal:  Nat Med       Date:  2011-11-20       Impact factor: 53.440

3.  SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination.

Authors:  Nichole R Klatt; Carol L Vinton; Rebecca M Lynch; Lauren A Canary; Jason Ho; Patricia A Darrah; Jacob D Estes; Robert A Seder; Susan L Moir; Jason M Brenchley
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

4.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

5.  Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.

Authors:  Thorsten Demberg; Venkatramanan Mohanram; David Venzon; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

Review 6.  The role of the immune system in governing host-microbe interactions in the intestine.

Authors:  Eric M Brown; Manish Sadarangani; B Brett Finlay
Journal:  Nat Immunol       Date:  2013-07       Impact factor: 25.606

7.  HIV-gp160 modulates differentially the production in vitro of IgG, IgA and cytokines by blood and tonsil B lymphocytes from HIV-negative individuals.

Authors:  F Cognasse; L Béniguel; R El Habib; O Sabido; P Chavarin; C Genin; O Garraud
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

8.  Mucosal immunity to HIV: a review of recent literature.

Authors:  Barbara L Shacklett
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

Review 9.  B cells in HIV infection and disease.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

10.  Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.

Authors:  D E Nilssen; O Øktedalen; P Brandtzaeg
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.